Skip to content
Checked.be
Complete company report
Generated 09-08-2026
Active BE 0832.350.565Public limited company

PharmaFluidics

Technologiepark-Zwijnaarde 82 ·9052 Gent, Belgium· 15 yrs active
Sector: Human health (86910)
Conclusion Checked

The computed 12-month bankruptcy probability of PharmaFluidics is 0.1% (very low). The company has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Based on State Gazette and CBE data.
Key figures
Active 15 yrs
Locations 1
Publications 33
Bankruptcy probability (12 mo) Checked model v1 · free
0.1% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector −Lower-risk legal form −Long track record −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based
0 / 100
Low risk
Trust signals 3 signals
Established
Founded in 2010, 15 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags 0 events
No administrative flags
Financial overview10 NBB filings
Financials being processed
NBB has 10 filing(s) on record for this company, latest fiscal year 2025 (verkort). The annual accounts are being processed.
Filings on record
Fiscal year Type Filed Reference
31-12-2025 verkort 08-06-2026 2026-00153437
31-12-2024 verkort 11-06-2025 2025-00151169
31-12-2023 verkort 26-07-2024 2024-00305440
31-12-2022 verkort 14-07-2023 2023-00258902
31-12-2021 verkort 12-07-2022 2022-20187112
31-12-2020 verkort 08-06-2021 2021-18900600
31-12-2019 verkort 03-07-2020 2020-26800021
31-12-2018 verkort 15-07-2019 2019-33500184
31-12-2017 verkort 29-06-2018 2018-29200217
31-12-2016 verkort 06-06-2017 2017-15100560
Legal Structure
NACE primary Human health(86910)
Legal form Public limited company(014)
Incorporation29-12-2010
StatusActive
Postal code9052
Establishment units 1 location
PharmaFluidics
Technologiepark-Zwijnaarde 82, 9052 GentVervaardiging van overige machines en apparaten voor algemeen gebruik, neg
since 20112.195.319.836
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44082B0143/00K000 Flanders 2,851 m² 1 · 1,922 m² 6.3 m · 2 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates 43 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2026
08-06-2026
NBB filing Annual accounts filed
fiscal year 2025 · verkort
2025
03-10-2025
State Gazette act Director changes
v3.2
07-07-2025
State Gazette act Director changes
v3.2
11-06-2025
NBB filing Annual accounts filed
fiscal year 2024 · verkort
26-02-2025
State Gazette act Director changes
v3.2
2024
26-07-2024
NBB filing Annual accounts filed
fiscal year 2023 · verkort
29-02-2024
State Gazette act Capital & shares
v3.2
2023
20-12-2023
State Gazette act Capital & shares
v3.2
11-10-2023
State Gazette act Director changes
v3.2
05-09-2023
State Gazette act Director changes
v3.2
14-07-2023
NBB filing Annual accounts filed
fiscal year 2022 · verkort
2022
31-08-2022
State Gazette act Director changes
v3.2
12-07-2022
NBB filing Annual accounts filed
fiscal year 2021 · verkort
2021
08-11-2021
State Gazette act Director changes
v3.2
01-10-2021
State Gazette act Statutes amendment
v3.2
06-09-2021
State Gazette act Director changes
v3.2
02-09-2021
State Gazette act Capital & shares
v3.2
02-09-2021
State Gazette act Miscellaneous
other · Ward BULTEREYS
02-08-2021
State Gazette act Capital & shares
v3.2
08-06-2021
NBB filing Annual accounts filed
fiscal year 2020 · verkort
2020
08-12-2020
State Gazette act Director changes
v3.2
09-09-2020
State Gazette act Capital & shares
v3.2
03-07-2020
NBB filing Annual accounts filed
fiscal year 2019 · verkort
23-06-2020
State Gazette act Director changes
v3.2
2019
30-12-2019
State Gazette act Capital & shares
v3.2
19-11-2019
State Gazette act Director changes
v3.2
15-07-2019
NBB filing Annual accounts filed
fiscal year 2018 · verkort
08-07-2019
State Gazette act Capital & shares
v3.2
12-02-2019
State Gazette act Registered-office change
Acorus BVBA
08-02-2019
State Gazette act Director changes
v3.2
2018
29-06-2018
NBB filing Annual accounts filed
fiscal year 2017 · verkort
22-01-2018
State Gazette act Capital & shares
v3.2
2017
06-10-2017
State Gazette act Director changes
v3.2
05-09-2017
State Gazette act Capital & shares
v3.2
06-06-2017
NBB filing Annual accounts filed
fiscal year 2016 · verkort
27-04-2017
State Gazette act Director changes
v3.2
02-02-2017
State Gazette act Capital & shares
v3.2
12-01-2017
State Gazette act Director changes
v3.2
2016
14-10-2016
State Gazette act Director changes
v3.2
30-08-2016
State Gazette act Miscellaneous
other · J&P BVBA
24-05-2016
State Gazette act Director changes
v3.2
08-03-2016
State Gazette act Director changes
v3.2
2015
29-07-2015
State Gazette act Capital & shares
v3.2
Belgisch Staatsblad, acts 33 acts
Capital history · 11
29-02-2024
v3.2
20-12-2023
v3.2
02-09-2021
v3.2
02-08-2021
v3.2
09-09-2020
v3.2
30-12-2019
v3.2
08-07-2019
v3.2
22-01-2018
v3.2
05-09-2017
v3.2
02-02-2017
v3.2
29-07-2015
v3.2
Address history · 1
12-02-2019
Registered-office move
All acts · 33 updated 10 months ago
2025
03-10-2025 1 director appointed, 1 resigning Director changes
  • Paul JACOBS, Bestuurder
  • Yves MOENS, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Yves MOENS",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Paul JACOBS",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PHARMAFLUIDICS"
  }
}
07-07-2025 2 resigning Director changes
  • Ines Brückel, Dagelijks bestuurder
  • Marion Murail, Dagelijks bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "dagelijks bestuurder",
      "person": {
        "rrn": null,
        "name": "Ines Br\u00FCckel",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "dagelijks bestuurder",
      "person": {
        "rrn": null,
        "name": "Marion Murail",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PHARMAFLUIDICS"
  }
}
26-02-2025 Change in the board of directors Director changes
Summary: v3.2
Technical details 
{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PHARMAFLUIDICS"
  }
}
2024
29-02-2024 Capital decrease of €1 to €21,854,945.46 Capital & shares
  • €21.854.946,46 → €21.854.945,46
  • Inbreng in geld · Apport en numéraire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_decrease",
      "after_eur": 21854945.46,
      "delta_eur": -1.0,
      "before_eur": 21854946.46,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PharmaFluidics"
  }
}
2023
20-12-2023 Capital increase of €20,000,000 to €21,854,946.46 Capital & shares
  • €1.854.946,46 → €21.854.946,46
  • Inbreng in geld · Apport en numéraire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 21854946.46,
      "delta_eur": 20000000.0,
      "before_eur": 1854946.46,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PharmaFluidics"
  }
}
11-10-2023 Franciscus VAN VEEN resigns as director Director changes
  • Franciscus VAN VEEN, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Franciscus VAN VEEN",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PHARMAFLUIDICS"
  }
}
05-09-2023 BDO Bedrijfsrevisoren appointed as statutory auditor Director changes
  • BDO Bedrijfsrevisoren, Commissaris
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "BDO Bedrijfsrevisoren",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PHARMAFLUIDICS"
  }
}
2022
31-08-2022 3 directors appointed, 2 resigning Director changes
  • Paul JACOBS, Dagelijks bestuurder
  • Ines BRUECKEL, Dagelijks bestuurder
  • Marion MURAIL, Dagelijks bestuurder
  • Johan DEVENYNS, Dagelijks bestuurder
  • Bart CATRYSSE, Dagelijks bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "dagelijks bestuurder",
      "person": {
        "rrn": null,
        "name": "Johan DEVENYNS",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "dagelijks bestuurder",
      "person": {
        "rrn": null,
        "name": "Bart CATRYSSE",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "dagelijks bestuurder",
      "person": {
        "rrn": null,
        "name": "Paul JACOBS",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "dagelijks bestuurder",
      "person": {
        "rrn": null,
        "name": "Ines BRUECKEL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "dagelijks bestuurder",
      "person": {
        "rrn": null,
        "name": "Marion MURAIL",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PHARMAFLUIDICS"
  }
}
2021
08-11-2021 2 directors appointed, 2 resigning Director changes
  • Johan Devenyns, Dagelijks bestuur
  • Bart Catrysse, Dagelijks bestuur
  • Johan Devenyns, Dagelijks bestuur
  • Acorus BV, Dagelijks bestuur
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "dagelijks bestuur",
      "person": {
        "rrn": null,
        "name": "Johan Devenyns",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "dagelijks bestuur",
      "person": {
        "rrn": null,
        "name": "Bart Catrysse",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "dagelijks bestuur",
      "person": {
        "rrn": null,
        "name": "Johan Devenyns",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "dagelijks bestuur",
      "person": {
        "rrn": null,
        "name": "Acorus BV",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PharmaFluidics"
  }
}
01-10-2021 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": true
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PharmaFluidics"
  },
  "legal_form_change": {
    "new": "naamloze vennootschap",
    "old": "naamloze vennootschap",
    "changed": false
  }
}
06-09-2021 1 director appointed, 1 resigning Director changes
  • Tine Bekaert, Vaste vertegenwoordiger van bestuurder
  • Jeroen Van den Bossche, Vaste vertegenwoordiger van bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "vaste vertegenwoordiger van bestuurder",
      "person": {
        "rrn": null,
        "name": "Jeroen Van den Bossche",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "vaste vertegenwoordiger van bestuurder",
      "person": {
        "rrn": null,
        "name": "Tine Bekaert",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PharmaFluidics"
  }
}
02-09-2021 Capital increase of €1,083,885.22 to €12,037,031.57 Capital & shares
  • €10.953.146,35 → €12.037.031,57
  • Inbreng in geld · Apport en numéraire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 12037031.57,
      "delta_eur": 1083885.2200000007,
      "before_eur": 10953146.35,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PharmaFluidics"
  }
}
02-09-2021 Publication in the Belgian Official Gazette, Miscellaneous Miscellaneous·Ward BULTEREYS
Summary: otherNotary: Ward BULTEREYS · Merelbeke (Bottelare)Firm: HENRIST, DE MULDER EN BULTEREYS, GEASSOCIEERDE NOTARISSEN
Technical details 
{
  "stage": null,
  "notary": {
    "name": "Ward BULTEREYS",
    "firm_city": null,
    "firm_name": "HENRIST, DE MULDER EN BULTEREYS, GEASSOCIEERDE NOTARISSEN",
    "office_city": "Merelbeke (Bottelare)",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2021-09-02",
    "filing_date": "2021-08-31",
    "act_kind_objet": "DIVERSEN"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2021-08-24",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0832.350.565",
        "name": "PharmaFluidics",
        "role": "other",
        "address": "Technologiepark-Zwijnaarde 82, 9052 Gent",
        "is_foreign": false,
        "legal_form": "Naamloze vennootschap",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": "De overdracht van vermogen betreft de annulatie en vernietiging van \u0027Adjustment Warrants\u0027 uitgegeven door de vennootschap, inclusief drie \u0027Adjustment Warrants I\u0027 en drie \u0027Adjustment Warrants II\u0027 uit 2017.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PharmaFluidics",
    "legal_form": "Naamloze vennootschap"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "Baker McKenzie",
    "person_name": null,
    "org_rep_person_name": "Kristoff Cox"
  },
  "summary_narrative": "De buitengewone algemene vergadering van PharmaFluidics besliste op 24 augustus 2021 tot annulatie en vernietiging van alle \u0027Adjustment Warrants\u0027 uitgegeven door de vennootschap, met inbegrip van drie \u0027Adjustment Warrants I\u0027 en drie \u0027Adjustment Warrants II\u0027 uit 2017. De vergadering verleende daarna machten aan het bestuursorgaan, de notaris en bepaalde vertegenwoordigers van Baker McKenzie voor de uitvoering van de besluiten en de formaliteiten bij de Kruispuntbank van Ondernemingen.",
  "co_filed_documents": [
    "uitgifte van het proces-verbaal",
    "aanwezigheidslijst met daaraan gehecht zevenentwintig (27) volmachten"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "statutes"
}
02-08-2021 Capital increase of €2,547,937.90 to €10,953,146.35 Capital & shares
  • €8.405.208,45 → €10.953.146,35
  • Inbreng in geld · Apport en numéraire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 10953146.35,
      "delta_eur": 2547937.9000000004,
      "before_eur": 8405208.45,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PharmaFluidics"
  }
}
2020
08-12-2020 1 director appointed, 1 resigning Director changes
  • Jeroen Van den Bossche, Vaste vertegenwoordiger bestuurder
  • Philippe Stas, Vaste vertegenwoordiger bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "vaste vertegenwoordiger bestuurder",
      "person": {
        "rrn": null,
        "name": "Philippe Stas",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "vaste vertegenwoordiger bestuurder",
      "person": {
        "rrn": null,
        "name": "Jeroen Van den Bossche",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PharmaFluidics"
  }
}
09-09-2020 Transaction in capital or shares Capital & shares
Summary: v3.2
Technical details 
{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PharmaFluidics"
  }
}
23-06-2020 4 directors appointed, 3 resigning Director changes
  • PMV NV, Bestuurder
  • Heran Partners BV, Bestuurder
  • RR-Invest Sàrl, Bestuurder
  • BDO Bedrijfsrevisoren, Commissaris
  • David Devigne, Bestuurder
  • Annie Vereecken, Bestuurder
  • Rudi Mariën, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "David Devigne",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "PMV NV",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Annie Vereecken",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Heran Partners BV",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Rudi Mari\u00EBn",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "RR-Invest S\u00E0rl",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "BDO Bedrijfsrevisoren",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PharmaFluidics"
  }
}
2019
30-12-2019 Capital decrease of €9,535,278.68 to €5,202,183.34 Capital & shares
  • €14.737.462,02 → €5.202.183,34
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_decrease",
      "after_eur": 5202183.34,
      "delta_eur": -9535278.68,
      "before_eur": 14737462.02,
      "contribution_type": null
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PharmaFluidics"
  }
}
19-11-2019 1 director appointed, 1 resigning Director changes
  • Veerle Catry, Vaste vertegenwoordiger commissaris
  • Bert Kegels, Vaste vertegenwoordiger commissaris
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "vaste vertegenwoordiger commissaris",
      "person": {
        "rrn": null,
        "name": "Bert Kegels",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "vaste vertegenwoordiger commissaris",
      "person": {
        "rrn": null,
        "name": "Veerle Catry",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PharmaFluidics"
  }
}
08-07-2019 Capital increase of €856,276.67 to €12,493,744.42 Capital & shares
  • €11.637.467,75 → €12.493.744,42
  • Inbreng in geld · Apport en numéraire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 12493744.42,
      "delta_eur": 856276.6699999999,
      "before_eur": 11637467.75,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PharmaFluidics"
  }
}
12-02-2019 Registered office moved within Zwijnaarde Registered-office change·Acorus BVBA
  • Technologiepark Zwijnaarde 3, 9052 Zwijnaarde → Technologiepark 82, 9052 Zwijnaarde
Notary: Acorus BVBA · Gent
Technical details 
{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "siege_social",
      "new_address": {
        "raw": "Technologiepark 82, 9052 Zwijnaarde",
        "city": "Zwijnaarde",
        "region": "vlaams_gewest",
        "street": "Technologiepark",
        "country": "BE",
        "postcode": "9052",
        "box_number": null,
        "street_number": "82",
        "locality_suffix": null
      },
      "old_address": {
        "raw": "Technologiepark Zwijnaarde 3, 9052 Zwijnaarde",
        "city": "Zwijnaarde",
        "region": "vlaams_gewest",
        "street": "Technologiepark Zwijnaarde",
        "country": "BE",
        "postcode": "9052",
        "box_number": null,
        "street_number": "3",
        "locality_suffix": null
      },
      "effective_date": "2019-01-01",
      "evidence_quote": "De Raad van Bestuur neemt kennis van de beslissing van de Stad Gent tot de doorvoering van een hernummering in het Technologiepark te Zwijnaarde, waardoor het adres van de maatschappelijke zetel van de vennootschap per 1 januari 2019 gewijzigd wordt naar: Technologiepark 82, 9052 Zwijnaarde.",
      "region_changed": false,
      "is_statute_change": false,
      "nationality_change": false,
      "old_address_source": "act_body",
      "statute_clause_text": null,
      "statute_article_number": null,
      "effective_date_qualifier": "absolute",
      "statutaire_vs_werkelijke": "statutaire",
      "linguistic_region_changed": false,
      "court_jurisdiction_changed": false,
      "effective_date_is_approximate": false
    }
  ],
  "notary": {
    "name": "Acorus BVBA",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Gent",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2019-02-12",
    "filing_date": "2019-01-31",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "date": "2018-12-18",
    "unanimous": true
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PharmaFluidics",
    "legal_form": "NV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Johan Devenyns",
    "org_rep_person_name": null,
    "person_role_at_subject": "Gedelegeerd bestuurder"
  },
  "co_filed_documents": [
    "Uittreksel uit het verslag van de Raad van Bestuur van 18 december 2018"
  ]
}
08-02-2019 1 director appointed, 1 resigning Director changes
  • Gert Desmet, A bestuurder
  • Kastel BVBA, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Kastel BVBA",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "A-Bestuurder",
      "person": {
        "rrn": null,
        "name": "Gert Desmet",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PharmaFluidics"
  }
}
2018
22-01-2018 Capital increase of €4,535,699.10 to €8,905,414.55 Capital & shares
  • €4.369.715,45 → €8.905.414,55
  • Inbreng in geld · Apport en numéraire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 8905414.55,
      "delta_eur": 4535699.100000001,
      "before_eur": 4369715.45,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PHARMAFLUIDICS"
  }
}
2017
06-10-2017 2 directors appointed Director changes
  • BDO Bedrijfsrevisoren, Commissaris
  • Farajollah Fashad (Fasha) Mahjoor, Onafhankelijk bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "BDO Bedrijfsrevisoren",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "onafhankelijk bestuurder",
      "person": {
        "rrn": null,
        "name": "Farajollah Fashad (Fasha) Mahjoor",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PharmaFluidics"
  }
}
05-09-2017 Capital increase of €1,019,184 to €4,369,715.45 Capital & shares
  • €3.350.531,45 → €4.369.715,45
  • Inbreng in geld · Apport en numéraire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 4369715.45,
      "delta_eur": 1019184.0,
      "before_eur": 3350531.45,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PHARMAFLUIDICS"
  }
}
27-04-2017 1 director appointed, 1 resigning Director changes
  • Marie Bouillez, Vaste vertegenwoordiger
  • Jean Van Nuwenborg, Vaste vertegenwoordiger
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "vaste vertegenwoordiger",
      "person": {
        "rrn": null,
        "name": "Jean Van Nuwenborg",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "vaste vertegenwoordiger",
      "person": {
        "rrn": null,
        "name": "Marie Bouillez",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PHARMAFLUIDICS"
  }
}
02-02-2017 Capital increase of €92,944.38 to €3,340,299.83 Capital & shares
  • €3.247.355,45 → €3.340.299,83
  • Inbreng in natura · Apport en nature
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 3340299.83,
      "delta_eur": 92944.37999999989,
      "before_eur": 3247355.45,
      "contribution_type": "natura"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PHARMAFLUIDICS"
  }
}
12-01-2017 10 directors appointed, 1 resigning Director changes
  • DE MALSCHE Wim, Bestuurder a
  • DEVIGNE David Jacques Martine, Bestuurder b
  • GONNISSEN Danny Henri Jean Marie, Bestuurder b
  • THEODORUS III, Bestuurder b
  • VAN NUWENBORG Jean Emile Léon Joseph, Bestuurder b
  • VERLEYSEN Katleen Rita Jozef Mariette Julien, Onafhankelijke bestuurder
  • SAS K.B.K., Onafhankelijke bestuurder
  • DESMET Gert, Gewone bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "LABEUR Christine",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder A",
      "person": {
        "rrn": null,
        "name": "DE MALSCHE Wim",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder B",
      "person": {
        "rrn": null,
        "name": "DEVIGNE David Jacques Martine",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder B",
      "person": {
        "rrn": null,
        "name": "GONNISSEN Danny Henri Jean Marie",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder B",
      "person": {
        "rrn": null,
        "name": "THEODORUS III",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder B",
      "person": {
        "rrn": null,
        "name": "VAN NUWENBORG Jean Emile L\u00E9on Joseph",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "onafhankelijke bestuurder",
      "person": {
        "rrn": null,
        "name": "VERLEYSEN Katleen Rita Jozef Mariette Julien",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "onafhankelijke bestuurder",
      "person": {
        "rrn": null,
        "name": "SAS K.B.K.",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "gewone bestuurder",
      "person": {
        "rrn": null,
        "name": "DESMET Gert",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd bestuurder",
      "person": {
        "rrn": null,
        "name": "ACORUS",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd bestuurder",
      "person": {
        "rrn": null,
        "name": "DEVENYNS Johan Andr\u00E9 Hubert",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PHARMAFLUIDICS"
  }
}
2016
14-10-2016 1 director appointed, 1 resigning Director changes
  • BVBA ACORUS, Bestuurder
  • BVBA J&P, Dagelijks bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "BVBA ACORUS",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "dagelijks bestuurder",
      "person": {
        "rrn": null,
        "name": "BVBA J\u0026P",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "PHARMAFLUIDICS"
  }
}
30-08-2016 Publication in the Belgian Official Gazette, Miscellaneous Miscellaneous·J&P BVBA
Summary: otherNotary: J&P BVBA · Gent
Technical details 
{
  "stage": null,
  "notary": {
    "name": "J\u0026P BVBA",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Gent",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2016-08-30",
    "filing_date": "2016-08-18",
    "act_kind_objet": "Neerlegging besluiten overeenkomstig art. 556 W. Venn."
  },
  "decision": {
    "body": "bijzondere_algemene_vergadering",
    "act_date": "2016-07-06",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0832.350.565",
        "name": "Pharmafluidics",
        "role": "other",
        "address": "Technologiepark Zwijnaarde 3, 9052 Zwijnaarde",
        "is_foreign": false,
        "legal_form": "Naamloze Vennootschap",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "556"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": "Geen overdracht van vermogen of reorganisatie; besluiten genomen overeenkomstig artikel 556 WVV in het kader van een bijzondere algemene vergadering van aandeelhouders.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0832.350.565",
    "name_full": "Pharmafluidics",
    "legal_form": "Naamloze Vennootschap"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "J\u0026P BVBA",
    "person_name": null,
    "org_rep_person_name": "JACOBS Paul"
  },
  "summary_narrative": "Op 6 juli 2016 hield de bijzondere algemene vergadering van aandeelhouders van Pharmafluidics, naamloze vennootschap met zetel te Zwijnaarde, een vergadering overeenkomstig artikel 556 van het Wetboek van Vennootschappen. De notulen van deze vergadering werden neergelegd bij de rechtbank van koophandel van Gent, afdeling Gent, op 18 augustus 2016.",
  "co_filed_documents": [],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "statutes"
}
First 30 of 33 acts
Credit advice verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.
AI due-diligence brief Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works
Company registry (CBE) Crossroads Bank
Activities
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72109Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72190Activiteiten van medische laboratoria86901Activiteiten van medische beeldvorming en medische laboratoria86910Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies70200Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering70220
Primary activity highlighted.
Names & trade names
Legal nameNL PharmaFluidics
Registered office
Technologiepark-Zwijnaarde 82
9052 Gent, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies Same NACE
CELL-CELL BIO BE 0782.638.362 · Gent
BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL BE 0475.471.036 · Gent
Btw-eenheid Argonaut BE 0798.359.587 · Gent
Cerba Research BE 0425.663.615 · Gent
Eurofins Amatsigroup BE 0893.062.073 · Gent
Source: Belgian State Gazette, CBE, NBB · generated via checked.be · indicative